Drug Interruption

Drug Interruption is a clinical management strategy within the domain of pulmonary toxicity management that consists of the temporary cessation of a pharmacological agent to mitigate or prevent drug-induced lung injury while preserving the potential for subsequent therapeutic re-initiation.

164

Publications

10.3K

Citations

1.2K

Authors

486

Institutions

Publications per year

2017–2026

57

Authors

1.2K

  1. JD
    James D. Douketis

    McMaster University, Canada

    7 publications · 2.6K citations

    7

    h-index

  2. AC
    Alex C. Spyropoulos

    Northwell Health, United States

    5 publications · 2.4K citations

    5

    h-index

  3. AP
    Alvisa Palese

    University of Udine, Italy

    3 publications · 198 citations

    3

    h-index

  4. SA
    Sameer A. Parikh

    Mayo Clinic in Arizona, United States

    3 publications · 111 citations

    3

    h-index

  5. MT
    Makoto Tahara

    National Cancer Center Hospital East, Japan

    3 publications · 136 citations

    3

    h-index

1–5 of 1.2K

Venues

  1. AIDS

    5 publications · 449 citations

    5

    h-index

  2. PubMed

    Repository · 4 publications · 98 citations

    4

    h-index

  3. Melanoma Research

    4 publications · 68 citations

    4

    h-index

  4. Journal of Nursing Management

    4 publications · 229 citations

    4

    h-index

  5. PLoS ONE

    4 publications · 170 citations

    4

    h-index

1–5